A detailed history of Sei Investments CO transactions in Axonics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 3,533 shares of AXNX stock, worth $245,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,533
Previous 33,597 89.48%
Holding current value
$245,366
Previous $2.32 Million 89.77%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$66.47 - $69.65 $2 Million - $2.09 Million
-30,064 Reduced 89.48%
3,533 $237,000
Q1 2024

May 07, 2024

SELL
$56.67 - $69.36 $4.08 Million - $4.99 Million
-71,992 Reduced 68.18%
33,597 $2.32 Million
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $983,649 - $1.27 Million
19,920 Added 23.25%
105,589 $6.57 Million
Q3 2023

Nov 14, 2023

SELL
$48.64 - $62.51 $345,879 - $444,508
-7,111 Reduced 7.66%
85,669 $4.81 Million
Q2 2023

Aug 11, 2023

SELL
$47.99 - $60.21 $2.69 Million - $3.37 Million
-56,026 Reduced 37.65%
92,780 $4.68 Million
Q1 2023

May 12, 2023

BUY
$52.6 - $67.34 $3.87 Million - $4.96 Million
73,619 Added 97.91%
148,806 $8.12 Million
Q4 2022

Feb 10, 2023

SELL
$59.56 - $76.6 $5.03 Million - $6.47 Million
-84,477 Reduced 52.91%
75,187 $4.7 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $277,628 - $374,194
4,790 Added 3.09%
159,664 $11.2 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $3.91 Million - $6.37 Million
98,915 Added 176.76%
154,874 $8.78 Million
Q1 2022

May 13, 2022

SELL
$43.74 - $62.76 $250,149 - $358,924
-5,719 Reduced 9.27%
55,959 $3.5 Million
Q4 2021

Feb 14, 2022

SELL
$50.01 - $73.35 $685,887 - $1.01 Million
-13,715 Reduced 18.19%
61,678 $3.45 Million
Q3 2021

Nov 12, 2021

BUY
$59.21 - $78.66 $722,835 - $960,281
12,208 Added 19.32%
75,393 $4.91 Million
Q2 2021

Aug 06, 2021

BUY
$51.39 - $66.9 $482,346 - $627,923
9,386 Added 17.45%
63,185 $4.01 Million
Q1 2021

May 12, 2021

SELL
$49.14 - $59.89 $475,527 - $579,555
-9,677 Reduced 15.25%
53,799 $3.22 Million
Q4 2020

Feb 08, 2021

SELL
$42.19 - $51.5 $285,541 - $348,552
-6,768 Reduced 9.63%
63,476 $3.17 Million
Q3 2020

Nov 06, 2020

BUY
$35.33 - $51.04 $914,234 - $1.32 Million
25,877 Added 58.32%
70,244 $3.59 Million
Q2 2020

Aug 17, 2020

BUY
$22.91 - $39.83 $309,789 - $538,581
13,522 Added 43.84%
44,367 $1.56 Million
Q2 2020

Aug 11, 2020

BUY
$22.91 - $39.83 $67,630 - $117,578
2,952 Added 10.58%
30,845 $855,000
Q1 2020

May 14, 2020

SELL
$16.44 - $37.73 $48,530 - $111,378
-2,952 Reduced 9.57%
27,893 $709,000
Q4 2019

Feb 06, 2020

BUY
$19.57 - $28.96 $377,603 - $558,783
19,295 Added 167.06%
30,845 $855,000
Q3 2019

Nov 12, 2019

SELL
$26.92 - $42.41 $37,472 - $59,034
-1,392 Reduced 10.76%
11,550 $311,000
Q2 2019

Aug 14, 2019

BUY
$18.54 - $40.97 $239,944 - $530,233
12,942 New
12,942 $530,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.41B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.